Legal Blog

DOJ Aggressively Pursues Health Care Fraud in 2019

In the first half of 2019, the United States Department of Justice (“DOJ”) has shown that it intends to aggressively pursue health care providers who engage in fraudulent schemes to enrich themselves at the expense of their patients and American taxpayers. The DOJ has...

The DNA of Medicare Fraud & the False Claims Act

Genetic Testing Laboratory Pays $2 Million to Settle Allegations of Medicare Fraud The Justice Department announced a settlement last month with GenomeDx Biosciences Corp. (“GenomeDx”), a genetic testing laboratory based in Vancouver, British Columbia with offices in...

The High Price of Attempted Whistleblower Retaliation

Barclays fined $15 Million for CEO’s Attempt to Identify Whistleblowers The New York Department of Financial Services (DFS) issued a press release this past December  announcing a $15 million penalty against Barclays Bank PLC for violations of New York state banking...

5G Cancer Risks: Asbestos of a New Generation?

The next generation of cell phone technology could pose serious cancer risks to the public You have probably already heard about 5G and the plans to roll out the new technology over the next two years. 5G is the new fifth-generation wireless broadband technology that...

New Tariffs Create Greater Incentives for Customs Fraud

Domestic importers are paying record amounts in customs duties due to a recent surge in the number of new tariffs, according to a recent article in the Wall Street Journal. In October, American companies paid $6.2 billion in duties, including $2.8 billion in new...

Sobering News of Fraud in the Addiction Treatment Industry

The opioid epidemic has exacted an immeasurable cost on our country in both human and financial costs. It has also given rise to a new type of health care scam in America - addiction treatment fraud. Unscrupulous operators of drug treatment centers and sober homes are...

Do Drug and Healthcare Ads Push Ethical Boundaries?

In the past four years, pharmaceutical companies have more than doubled their ad spending, making it the second-fastest growing ad category in the nation. Other healthcare providers, from local hospitals to nationally known cancer treatment centers, are also...

Behind the Opioid Epidemic

The United States Department of Justice and numerous state governments have intervened in numerous qui tam whistleblower suits, including one brought by Philadelphia based law firm Young Law Group against INSYS Therapeutics, Inc. [1]. The suit alleges, among other...

Key Whistleblower Changes in Bipartisan Budget Act

The Bipartisan Budget Act of 2018, passed overnight and signed this morning by President Trump to end the second federal government shutdown of this year, includes two key provisions for whistleblowers previously introduced by Senator Charles Grassley but removed from...